The drugmaker Eli Lilly and Company said on Wednesday that it would significantly reduce the sticker prices of several of its lifesaving insulin products that are used by diabetes patients and whose prices Lilly has repeatedly increased in the past. Seeking to quiet an outcry about excessive drug …